KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis.

The Kidney Disease Outcomes Quality Initiative (KDOQI) convened a work group to review the KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis. The KDOQI work group reviewed the Kidney Disease: Improving Global Outcomes (KDIGO) guideline statements and practice points and provided perspective for implementation within the context of clinical practice in the United States. Overall, the KDOQI work group agrees with the majority of the KDIGO guideline statements. Throughout this commentary, the KDOQI work group provides clarifications and additional areas for consideration when implementing these practice points.